US2002160458A1PendingUtilityA1
Method for the production of FVII
Priority: Nov 6, 1998Filed: Nov 13, 2001Published: Oct 31, 2002
Est. expiryNov 6, 2018(expired)· nominal 20-yr term from priority
C12N 9/6437C12Y 304/21021C12N 9/6424
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method for high efficiency release of recombinant proteins in eukaryotic cells and more specifically, for enhancing the secretion of Factor VII by co-expression of kex2 endoprotease with FVII in cells of mammalian origin.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for producing Factor VII comprising (a) cultivation of a mammalian cell line comprising a DNA sequence encoding a yeast endoprotease or a derivative thereof and a DNA sequence encoding FVII in a suitable culture medium; and (b) isolation of Factor VII from the medium.
2 . The method of claim 1 , wherein the yeast endoprotease is derived from a Saccharomyces strain.
3 . The method if claim 2 , wherein the yeast endoprotease is a Kex2 like endoprotease.
4 . The method of claim 3 wherein the yeast Kex2 like endoprotease is C-terminally truncated and has no transmembrane region.
5 . The method of claim 4 , wherein the yeast Kex2 like endoprotease has ER retention signal added to the C-terminal end.
6 . The method of claim 2 wherein the yeast endoprotease is the Kex2 endoprotease from Saccharomyces cerevisiae.
7 . The method of claim 1 , wherein the culture medium is a serum free medium.
8 . The method of claim 1 wherein the mammalian cell line is a CHO cell line.
9 . The method of claim 1 wherein the mammalian cell line is a BHK cell line.
10 . The method of claim 1 wherein the mammalian cell line is a HEK 293 cell line.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.